rs2501727

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_018249.6(CDK5RAP2):​c.2274T>C​(p.Asp758Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.122 in 1,613,736 control chromosomes in the GnomAD database, including 16,296 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 3729 hom., cov: 32)
Exomes 𝑓: 0.12 ( 12567 hom. )

Consequence

CDK5RAP2
NM_018249.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.311

Publications

22 publications found
Variant links:
Genes affected
CDK5RAP2 (HGNC:18672): (CDK5 regulatory subunit associated protein 2) This gene encodes a regulator of CDK5 (cyclin-dependent kinase 5) activity. The protein encoded by this gene is localized to the centrosome and Golgi complex, interacts with CDK5R1 and pericentrin (PCNT), plays a role in centriole engagement and microtubule nucleation, and has been linked to primary microcephaly and Alzheimer's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
CDK5RAP2 Gene-Disease associations (from GenCC):
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • microcephaly 3, primary, autosomal recessive
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • corpus callosum, agenesis of
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 9-120458551-A-G is Benign according to our data. Variant chr9-120458551-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136705.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.311 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.35 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK5RAP2NM_018249.6 linkc.2274T>C p.Asp758Asp synonymous_variant Exon 20 of 38 ENST00000349780.9 NP_060719.4 Q96SN8-1B3KVI2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK5RAP2ENST00000349780.9 linkc.2274T>C p.Asp758Asp synonymous_variant Exon 20 of 38 1 NM_018249.6 ENSP00000343818.4 Q96SN8-1

Frequencies

GnomAD3 genomes
AF:
0.186
AC:
28339
AN:
151978
Hom.:
3708
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.355
Gnomad AMI
AF:
0.171
Gnomad AMR
AF:
0.165
Gnomad ASJ
AF:
0.0856
Gnomad EAS
AF:
0.330
Gnomad SAS
AF:
0.147
Gnomad FIN
AF:
0.118
Gnomad MID
AF:
0.142
Gnomad NFE
AF:
0.0980
Gnomad OTH
AF:
0.160
GnomAD2 exomes
AF:
0.147
AC:
36956
AN:
251390
AF XY:
0.141
show subpopulations
Gnomad AFR exome
AF:
0.365
Gnomad AMR exome
AF:
0.153
Gnomad ASJ exome
AF:
0.0883
Gnomad EAS exome
AF:
0.319
Gnomad FIN exome
AF:
0.109
Gnomad NFE exome
AF:
0.102
Gnomad OTH exome
AF:
0.125
GnomAD4 exome
AF:
0.115
AC:
168786
AN:
1461640
Hom.:
12567
Cov.:
33
AF XY:
0.115
AC XY:
83606
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.359
AC:
12003
AN:
33470
American (AMR)
AF:
0.155
AC:
6935
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0837
AC:
2187
AN:
26136
East Asian (EAS)
AF:
0.353
AC:
14027
AN:
39692
South Asian (SAS)
AF:
0.137
AC:
11788
AN:
86252
European-Finnish (FIN)
AF:
0.109
AC:
5844
AN:
53420
Middle Eastern (MID)
AF:
0.133
AC:
769
AN:
5768
European-Non Finnish (NFE)
AF:
0.0963
AC:
107020
AN:
1111788
Other (OTH)
AF:
0.136
AC:
8213
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
7790
15579
23369
31158
38948
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4172
8344
12516
16688
20860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.187
AC:
28408
AN:
152096
Hom.:
3729
Cov.:
32
AF XY:
0.188
AC XY:
13972
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.355
AC:
14734
AN:
41486
American (AMR)
AF:
0.164
AC:
2512
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0856
AC:
297
AN:
3470
East Asian (EAS)
AF:
0.330
AC:
1705
AN:
5164
South Asian (SAS)
AF:
0.146
AC:
704
AN:
4824
European-Finnish (FIN)
AF:
0.118
AC:
1248
AN:
10572
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.0980
AC:
6665
AN:
67980
Other (OTH)
AF:
0.164
AC:
345
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1097
2194
3292
4389
5486
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.125
Hom.:
3321
Bravo
AF:
0.198
Asia WGS
AF:
0.292
AC:
1018
AN:
3478
EpiCase
AF:
0.0983
EpiControl
AF:
0.101

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 18, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Microcephaly 3, primary, autosomal recessive Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 28, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary Microcephaly, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.90
DANN
Benign
0.27
PhyloP100
-0.31
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2501727; hg19: chr9-123220829; COSMIC: COSV62572597; COSMIC: COSV62572597; API